ANI Pharmaceuticals (BSFA) Q3 2018 Earnings Report
0 Followers
CH:BSFA Q3 2018 EPS Results
- Actual EPS
- CHF 1.05
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- CHF 0.90
CH:BSFA Q3 2018 Revenue Results
- Actual Revenue
- CHF 41.29M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/06/2018
- Time
- Before Open
- Conference Call
- Tuesday, November 6, 2018
CH:BSFA Upcoming Earnings
ANI Pharmaceuticals's next earnings date is estimated for February 26, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSFA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 26, 2027 | 2026 (Q4) | ―- | 1.9 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 1.781.23 | 1.66 | -25.98% (-0.43) | |
| Aug 07, 2026 | 2026 (Q2) | 1.661.80 | 1.47 | 22.78% (+0.33) | |
| May 08, 2026 | 2026 (Q1) | 1.061.67 | 1.38 | 20.59% (+0.28) | |
| Mar 03, 2026 | 2025 (Q4) | 1.621.90 | 1.33 | 42.94% (+0.57) | |
| Nov 10, 2025 | 2025 (Q3) | 1.441.66 | 1.09 | 52.24% (+0.57) | |
| Aug 08, 2025 | 2025 (Q2) | 1.141.47 | 0.83 | 76.47% (+0.64) | |
| May 09, 2025 | 2025 (Q1) | 1.131.38 | 0.99 | 40.50% (+0.40) | |
| Feb 28, 2025 | 2024 (Q4) | 1.171.33 | 0.81 | 63.00% (+0.51) | |
| Nov 08, 2024 | 2024 (Q3) | 0.881.09 | 1.03 | 5.51% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
